Skip to main content
. 2015 Feb 13;6(6):695–703. doi: 10.1111/1759-7714.12239

Figure 2.

Figure 2

Impact of lapatinib on the estrogen receptor (ER)α and human epidermal growth factor receptor (HER)2 pathways in the sensitive strain cell BT474. (a) & (b) The of phosphorylation of HER2, protein kinase B (AKT), and extracellular-signal-related-kinase (ERK) of BT474 were reduced with 1 μM lapatinib, but the ER pathway was activated, which was manifested by the increased expression of ERα, PR, and forkhead-box (FOX)O3a at messenger ribonucleic acid (mRNA) and protein level (P < 0.05). Lap, lapatinib. Inline graphic, dimethyl sulfoxide (DMSO); Inline graphic, Lap (0.5 μM); Inline graphic, Lap (1 μM).